Topic
Nirsevimab
EU Infant RSV Study Finds Monoclonal Antibodies Outperform Maternal Vaccines
A continental modelling study reveals that long-acting monoclonal antibodies consistently outperform maternal vaccines in reducing infant RSV hospital admissions.